High Risk Covid Patient
- All
- News
-
WHO "Strongly Recommends" Pfizer's Antiviral Covid pill
The World Health Organization said Friday it "strongly recommended" Pfizer's Covid-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalisation.
-
WHO Gives Nod To Merck Covid Pill For Non-Severe, At-Risk Patients
The World Health Organization on Wednesday recommended an anti-Covid pill be taken by sufferers who have mild symptoms but are at high risk of hospitalisation, such as older people or the unvaccinated.
-
Patients With High Covid Risk Least Likely To Get Monoclonal Antibodies: Study
According to new research, people over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs). -- a highly effective treatment for the disease -- both across and within US states.
-
No Symptoms Or Not At "High Risk"? Don't Get Tested, Says Centre
Contacts of COVID-19 patients, unless identified as high-risk, don't need to be tested, says government
-
WHO Recommends Antibody Treatment For Critical Covid Patients. Details Here
COVID-19 patients at high risk of hospitalisation or those with severe disease should be given a combination of two antibody treatments, according to latest World Health Organisation guidelines published in The BMJ today.
-
Delhi's LNJP Hospital Begins Free Antibody Cocktail Therapy For Covid Patients
The Monoclonal Antibody Cocktail used to treat mild to moderate "high risk" Covid patients is now available at Delhi's Lok Nayak Jai Prakash Narayan Hospital (LNJP) for free.
-
WHO "Strongly Recommends" Pfizer's Antiviral Covid pill
The World Health Organization said Friday it "strongly recommended" Pfizer's Covid-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalisation.
-
WHO Gives Nod To Merck Covid Pill For Non-Severe, At-Risk Patients
The World Health Organization on Wednesday recommended an anti-Covid pill be taken by sufferers who have mild symptoms but are at high risk of hospitalisation, such as older people or the unvaccinated.
-
Patients With High Covid Risk Least Likely To Get Monoclonal Antibodies: Study
According to new research, people over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs). -- a highly effective treatment for the disease -- both across and within US states.
-
No Symptoms Or Not At "High Risk"? Don't Get Tested, Says Centre
Contacts of COVID-19 patients, unless identified as high-risk, don't need to be tested, says government
-
WHO Recommends Antibody Treatment For Critical Covid Patients. Details Here
COVID-19 patients at high risk of hospitalisation or those with severe disease should be given a combination of two antibody treatments, according to latest World Health Organisation guidelines published in The BMJ today.
-
Delhi's LNJP Hospital Begins Free Antibody Cocktail Therapy For Covid Patients
The Monoclonal Antibody Cocktail used to treat mild to moderate "high risk" Covid patients is now available at Delhi's Lok Nayak Jai Prakash Narayan Hospital (LNJP) for free.
